Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Return on Equity: 2011-2025

Historic Return on Equity for Mimedx Group (MDXG) over the last 13 years, with Sep 2025 value amounting to 0.18%.

  • Mimedx Group's Return on Equity rose 16.00% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 16.00%. This contributed to the annual value of 0.00% for FY2024, which is 15.00% up from last year.
  • Per Mimedx Group's latest filing, its Return on Equity stood at 0.18% for Q3 2025, which was up 54.70% from 0.12% recorded in Q2 2025.
  • Mimedx Group's Return on Equity's 5-year high stood at 12.89% during Q1 2021, with a 5-year trough of -0.13% in Q4 2023.
  • In the last 3 years, Mimedx Group's Return on Equity had a median value of 0.07% in 2025 and averaged 0.17%.
  • As far as peak fluctuations go, Mimedx Group's Return on Equity soared by 1,342bps in 2021, and later tumbled by 897bps in 2022.
  • Quarterly analysis of 5 years shows Mimedx Group's Return on Equity stood at 4.30% in 2021, then tumbled by 323bps to 1.06% in 2022, then crashed by 119bps to -0.13% in 2023, then grew by 17bps to 0.04% in 2024, then grew by 16bps to 0.18% in 2025.
  • Its Return on Equity was 0.18% in Q3 2025, compared to 0.12% in Q2 2025 and 0.07% in Q1 2025.